6:15 PM
 | 
Dec 18, 2012
 |  BC Extra  |  Financial News

Blend raises $16 million in series B

Blend Therapeutics Inc. (Watertown, Mass.) raised $16 million in a series B round led by existing investor NanoDimension. Existing investors Flagship Ventures and New Enterprise...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >